K-numberK251341
Device nameVITAL Tubing Sets for Hemodialysis
ApplicantVital Healthcare Sdn. Bhd.
Product codeFJK
Device classClass II
Decision dateJan 16, 2026
DecisionSubstantially Equivalent
Regulation876.5820
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

VITAL Tubing Sets for Hemodialysis are sterile, single-use arterial and venous blood lines designed for exclusive use with specific hemodialysis systems (AK98, Fresenius 2008/5008X, and Braun Dialog series). The tubing sets form the extracorporeal blood circuit that transports blood from the patient through a hemodialyzer and back to the patient, with the pump line interfacing with the hemodialysis machine's pump rotor mechanism.

Technological characteristics

The proposed device differs from the predicate in sterilization method (ethylene oxide vs. e-beam), materials composition (includes PCTG, PETG, MABS in addition to predicate materials), priming volumes that vary by model (88–201 mL depending on tubing length), and conformance to updated ISO standards (ISO 8637-2:2024 and ISO 80369-7:2021 vs. older ISO 8638:2010 and ISO 594-2:1998). Main configuration, features, and pressure limitations (±500 mmHg) remain substantially the same.

Test standards cited

ISO 11607-1:2019 and ISO 11607-2:2019 (packaging); ISO 8637-2:2024 and ISO 80369-7:2021 (performance); ASTM F88/F88M-23, F1929-23, F1980-21, D4169-23, and F2096-11 (mechanical/packaging testing); EN ISO 10993 series (biocompatibility and chemical characterization); EN ISO 11135:2014 (ethylene oxide sterilization validation); USP <85> (bacterial endotoxin).

Substantial equivalence argument

The proposed devices are substantially equivalent because they serve the same intended use (extracorporeal blood circuit in hemodialysis), have compatible system specifications with documented bench testing, and all functional and safety-critical characteristics match the predicate. Design differences in sterilization method, materials, and priming volumes do not introduce new safety or effectiveness issues, as demonstrated by comprehensive performance testing, biocompatibility studies, and compliance with applicable standards. Updated ISO standards do not create new risks.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →